Resources by Therapeutic Area
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, De Forges H, Firmin N, Guiu S, Jacot W and Lehmann S BMC Cancer. 2019 Jan 30;19(1):110 DOI: 10.1186/s12885-019-5287-z. Abstract BACKGROUND:
Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X™ Platform and CorPlex™ Validated 10-Plex
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development
The Quanterix SP-X Imaging and Analysis System is the first complete benchtop system offering true multiplex detection capabilities at both acute and baseline levels.
April 11-13, 2016 | Vienna, Austria The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy.
March 29-April 3, 2019 | Atlanta, GA | Booth #4063 **KOL Dinner Event April 1, 2019 | More Info / Request Invitation